REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

被引:0
|
作者
Raluy-Callado, Mireia
Carroll, Robert
Curtis, Rebecca
Khalid, Javaria Mona
Patel, Haridarshan
机构
关键词
D O I
10.1093/ibd/izy038.028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P190
引用
收藏
页码:S74 / S75
页数:2
相关论文
共 50 条
  • [1] REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
    Raluy-Callado, Mireia
    Carroll, Robert
    Curtis, Rebecca
    Khalid, Javaria Mona
    Patel, Haridarshan
    [J]. GASTROENTEROLOGY, 2018, 154 (01) : S105 - S106
  • [2] Colombian real-world experience of vedolizumab use in patients with inflammatory bowel disease-EXVEDOCOL
    Parra Izquierdo, V.
    Cifuentes Amortegui, S.
    Avendano R, S.
    Ponce de Leon, E.
    Florez, C.
    Reyes Medina, G.
    Puentes M, F. E.
    Ballesteros B, M.
    Nunez, E. E.
    Hemandez, M.
    Kock, J.
    Marquez, J. R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S181 - S182
  • [3] Benefit of measuring vedolizumab concentrations in inflammatory bowel disease patients in a real-world setting
    Kolehmainen, Sara
    Ylisaukko-Oja, Tero
    Jokelainen, Jari
    Koivusalo, Mirkka
    Jokiranta, T. Sakari
    Sipponen, Taina
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (08) : 906 - 913
  • [4] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    [J]. INFLAMMATORY BOWEL DISEASES, 2024, 30 : S73 - S74
  • [5] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Anjur, Kavya
    Neiman, Nicole
    Kotzen, Alison
    Pond, Stephen
    Goyal, Alka
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S826 - S826
  • [6] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE ADMINISTERED VEDOLIZUMAB FOR 6 MONTHS
    Cohen, Benjamin
    Chang, Helena L.
    Rogers, Jason
    Garg, Shashank
    Lawrence, Debra
    Fasihuddin, Farah
    Lissoos, Trevor
    Atreja, Ashish
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S659 - S659
  • [7] Real-world healthcare resource utilisation among patients with inflammatory bowel disease administered vedolizumab for 6 months
    Cohen, B.
    Chang, H.
    Rogers, J. R. Jason
    Garg, S.
    Lawrence, D.
    Fasihuddin, F.
    Lissoos, T.
    Atreja, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S058 - S059
  • [8] Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
    Plevris, N.
    Chuah, C. S.
    Allen, R. M.
    Arnott, I. D.
    Brennan, P. N.
    Chaudhary, S.
    Churchhouse, A. M. D.
    Din, S.
    Donoghue, E.
    Gaya, D. R.
    Groome, M.
    Jafferbhoy, H. M.
    Jenkinson, P. W.
    Lam, W. L.
    Lyons, M.
    Macdonald, J. C.
    MacMaster, M.
    Mowat, C.
    Naismith, G. D.
    Potts, L. F.
    Saffouri, E.
    Seenan, J. P.
    Sengupta, A.
    Shasi, P.
    Sutherland, D. I.
    Todd, J. A.
    Veryan, J.
    Watson, A. J. M.
    Watts, D. A.
    Jones, G. R.
    Lees, C. W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1111 - 1120
  • [9] Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
    Lamichhane, N.
    Melas, N.
    Bergqvist, V.
    Ekholm, N. -P.
    Olen, O.
    Ludvigsson, J. F.
    Hjortswang, H.
    Marsal, J.
    Eriksson, C.
    Halfvarson, J.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (06) : 2175 - 2183
  • [10] REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Mosli, Mahmoud
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward V., Jr.
    [J]. GASTROENTEROLOGY, 2018, 154 (01) : S82 - S82